NeuroBo Pharmaceuticals (NRBO)
(Delayed Data from NSDQ)
$3.57 USD
-0.42 (-10.41%)
Updated Aug 5, 2024 04:00 PM ET
After-Market: $3.57 0.00 (0.00%) 6:46 PM ET
NA Value
NA Growth NA Momentum NA VGMKey Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/14/2024
Time: -- |
6/2024 | $-1.38 | 0.00% |
Earnings Summary
For their last quarter, NeuroBo Pharmaceuticals (NRBO) reported earnings of -$1.32 per share, missing the Zacks Consensus Estimate of -$0.95 per share. This reflects a negative earnings surprise of 38.95%. Look out for NRBO's next earnings release expected on August 14, 2024. For the next earning release, we expect the company to report earnings of -$1.38 per share, reflecting a year-over-year decrease of 762.5%.
Earnings History
Price & Consensus
Zacks News for NRBO
4 Undervalued Medical Stocks to Buy Amid High Market Volatility
NRBO: What are Zacks experts saying now?
Zacks Private Portfolio Services